10.50 - 11.12
3.81 - 12.83
1.80M / 1.61M (Avg.)
158.14 | 0.07
Analyze analyst forecasts for the company and compare them with competitors.
961.13M
The estimated revenue has decreased from the previous period.
265.35M
The estimated EBITDA has decreased from the previous period.
1.38
The estimated EPS has decreased from the previous period.
462.20M
The estimated net income has decreased from the previous period.
203.68M
The estimated EBIT has decreased from the previous period.
675.58M
The estimated SG&A expenses have decreased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
138.47M
Revenue has increased from the previous period.
4585.50%
Revenue growth rate has increased from the previous period.
73.10M
EBITDA has increased from the previous period.
52.79%
EBITDA margin has increased from the previous period.
62.19M
EBIT has increased from the previous period.
44.91%
EBIT margin has increased from the previous period.
10.91M
Depreciation has increased from the previous period.
68.99M
Total cash has increased from the previous period.
49.83%
Cash percentage has decreased from the previous period.
6.47M
Receivables have decreased from the previous period.
4.67%
Receivables percentage has decreased from the previous period.
16.08M
Inventories have increased from the previous period.
11.61%
Inventory percentage has decreased from the previous period.
4.81M
Accounts payable has increased from the previous period.
3.47%
Payables percentage has decreased from the previous period.
-12.88M
Capital expenditure has decreased from the previous period.
-9.30%
CapEx percentage has decreased from the previous period.
9.15%
WACC has decreased from the previous period.
9.08%
Cost of equity is unchanged from the previous period.
293.12%
Cost of debt is unchanged from the previous period.
1.06
Beta is unchanged from the previous period.
333.90M
Diluted shares outstanding is unchanged from the previous period.
1.56M
Total debt is unchanged from the previous period.
3.49B
Total equity is unchanged from the previous period.
3.49B
Total capital is unchanged from the previous period.
0.04%
Debt weighting is unchanged from the previous period.
99.96%
Equity weighting is unchanged from the previous period.
36.30M
EBIAT has increased from the previous period.
31.48M
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
205.99M
Terminal value is unchanged from the previous period.
73.60M
Enterprise value has increased from the previous period.
-113.70M
Net debt is unchanged from the previous period.
187.30M
Equity value has increased from the previous period.
0.56
Equity value per share has increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$4.18
Has downside compared to CGAU's upside of 39.95%.
Buy
Equal to CGAU's analyst recommendation of Buy.
